tirzepatide surpass cvot Comparison of and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics Reduction of prevalence of patients
Description
Unlike the current widely used medications such as Ozempic and Mounjaro that target the GLP-1 pathway alone, retatrutide, known as a GLP-3, targets three pathways related to metabolism: GIP, GLP-1, and glucagon
All-Day Energy & Focus
Discover everything about Wegovy, the new GLP-1 weight loss injection now in South Africa
Fractyl Health has announced positive 6-month results from its open-label REVEAL-1 Cohort
Fast shipping from ProteoGenix.
Glucagon-like peptide-1 (GLP-1) agonists are the latest evolution of drugs that are reshaping the way we treat diabetes, obesity, and other forms of addiction.
